These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35388759)

  • 1. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
    Ma J; Na S; Wang P; Li J; He S; Liu F
    Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
    [No Abstract]   [Full Text] [Related]  

  • 3. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
    Zhu R; Mao Y; Xu X; Li Y; Zheng J
    Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.
    Li S; Fan T; Liu H; Chen J; Qin C; Ren X
    Mol Biol Rep; 2013 Oct; 40(10):5723-32. PubMed ID: 24057236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
    Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
    Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
    Hu D; Zhong T; Dai Q
    Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
    Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
    Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis.
    Li W; Zhu Q; Zhang S; Liu L; Zhang H; Zhu D
    Oral Oncol; 2020 Dec; 111():104946. PubMed ID: 32763778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
    Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
    Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
    Yao Y; Zhou WY; He RX
    Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
    Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
    Shiah SG; Hsiao JR; Chang HJ; Hsu YM; Wu GH; Peng HY; Chou ST; Kuo CC; Chang JY
    J Biomed Sci; 2020 Apr; 27(1):46. PubMed ID: 32238162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression levels of MMP-14, ING4 and HIF-1α in 60 patients with oral squamous cell carcinoma and their clinical significance].
    Fu ZY; Tao F
    Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):642-646. PubMed ID: 33778834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
    Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
    Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
    Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
    Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.